Your browser doesn't support javascript.
loading
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial.
Guarneri, Valentina; Bras-Maristany, Fara; Dieci, Maria Vittoria; Griguolo, Gaia; Par, Laia; Mar Ín-Aguilera, Mercedes; Miglietta, Federica; Bottosso, Michele; Giorgi, Carlo Alberto; Blasco, Paula; Castillo, Oleguer; Galv N, Patricia; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S; Perou, Charles M; Conte, PierFranco; Prat, Aleix.
Afiliação
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Bras-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Par L; Reveal Genomics, Barcelona, Spain.
  • Mar Ín-Aguilera M; Reveal Genomics, Barcelona, Spain.
  • Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Bottosso M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Giorgi CA; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Galv N P; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Villagrasa P; Reveal Genomics, Barcelona, Spain.
  • Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
  • Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA; Department of Genetics, University of North Carolina, Chapel Hill, USA.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Reveal Genomics, Barcelona, Spain; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain; Department of Medicine, University of Barcelona, Barcel
EBioMedicine ; 85: 104320, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36374768
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Holanda